BioCentury
DATA GRAPHICS | Deals

Data Bytes: upfront tally shows 2020’s dealmakers playing catch-up

September 11, 2020 12:16 AM UTC

Biopharmas need to plunk down at least $8.5 billion by year-end if the sector’s dealmakers hope to match last year’s disclosed upfront payments of $17.9 billion.

BioCentury has tracked $9.4 billion raised from January through August this year via disclosed up fronts from 108 global licensing deals and research collaborations, putting it behind the $11.5 billion raised across 128 deals over the same period last year. ...